ইউরোপীয় ইউনিয়ন - স্পেনীয় - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

স্পেন - স্পেনীয় - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sanofi aventis, s.a. - bromhexina hidrocloruro - excipientes: acido benzoico - expectorantes, excluyendo combinaciones con supresores de la tos - mucolíticos - bromhexina

স্পেন - স্পেনীয় - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

boehringer ingelheim españa, s.a. - bromhexina hidrocloruro - excipientes: acido benzoico,glicerol,sorbitol,alcohol etilico (etanol),carmelosa sodica - expectorantes, excluyendo combinaciones con supresores de la tos - mucolíticos - bromhexina

ইউরোপীয় ইউনিয়ন - স্পেনীয় - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).

স্পেন - স্পেনীয় - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

jaer, s.a. - bromhexina hidrocloruro - soluciÓn oral - excipientes: citrico, acido, metilparabeno (e 218), glicerol formal - bromhexina - bovino, caballos no destinados a consumo humano, gatos, perros, porcino

ইউরোপীয় ইউনিয়ন - স্পেনীয় - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

পিরু - স্পেনীয় - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

opella healthcare del peru s.a.c - droguerÍa - clorhidrato de bromhexina; - jarabe - por dosis - - bromhexina

পিরু - স্পেনীয় - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

medifarma s.a. - laboratorio - clorhidrato de bromhexina; - jarabe - por mililitro - - bromhexina

পিরু - স্পেনীয় - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

medifarma s.a. - laboratorio - clorhidrato de bromhexina; - jarabe - por mililitro 5.00 ml - - bromhexina

পিরু - স্পেনীয় - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

opella healthcare del peru s.a.c - droguerÍa - clorhidrato de bromhexina; - jarabe - por dosis - - bromhexina